Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: Systematic review and meta-analysis

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Msaouel, Pavlos ^a,b   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CIRCULATING TUMOR CELL; CLINICAL INDICATOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; META ANALYSIS; PATIENT ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; BLOOD; PATHOLOGY; PROGNOSIS; REVIEW; TUMOR EMBOLISM;

CARCINOMA, TRANSITIONAL CELL; HUMANS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 79961116885     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-336     Document Type: Article

References (59)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
3. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003, 44:672-681. 10.1016/S0302-2838(03)00416-0, 14644119.
4. Mazeman E. Tumors of the upper excretory urinary tract, calices, renal pelvis and ureter. J Urol Nephrol (Paris) 1972, 78(Suppl 9):1-219.
5. Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, Cussenot O, Hamdy FC. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 2007, 177:1715-1720. 10.1016/j.juro.2007.01.030, 17437794.
6. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998, 52:594-601. 10.1016/S0090-4295(98)00295-7, 9763077.
7. Edge SB, . American Joint Committee on Cancer, American Cancer Society AJCC cancer staging handbook: from the AJCC cancer staging manual 2010, New York: Springer, 7, American Joint Committee on Cancer, American Cancer Society.
8. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 2007, 51:137-149. discussion 149-151, 10.1016/j.eururo.2006.05.021, 16793197.
9. Raj GV, Bochner BH. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard. Semin Oncol 2007, 34:110-121. 10.1053/j.seminoncol.2006.12.011, 17382794.
10. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
11. Mocellin S, Keilholz U, Rossi CR, Nitti D. Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 2006, 12:130-139. 10.1016/j.molmed.2006.01.006, 16488189.
12. Msaouel P, Pissimissis N, Halapas A, Koutsilieris M. Mechanisms of bone metastasis in prostate cancer: clinical implications. Best Pract Res Clin Endocrinol Metab 2008, 22:341-355. 10.1016/j.beem.2008.01.011, 18471791.
13. Nezos A, Pissimisis N, Lembessis P, Sourla A, Dimopoulos P, Dimopoulos T, Tzelepis K, Koutsilieris M. Detection of circulating tumor cells in bladder cancer patients. Cancer Treat Rev 2009, 35:272-279. 10.1016/j.ctrv.2008.11.003, 19103472.
14. Nezos A, Msaouel P, Pissimissis N, Lembessis P, Sourla A, Armakolas A, Gogas H, Stratigos AJ, Katsambas AD, Koutsilieris M. Methods of detection of circulating melanoma cells: A comparative overview. Cancer Treat Rev 2011, 37:284-290. 10.1016/j.ctrv.2010.10.002, 21106295.
15. Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 2006, 33:S9-14.
16. Gudemann CJ, Weitz J, Kienle P, Lacroix J, Wiesel MJ, Soder M, Benner A, Staehler G, Doeberitz MV. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma. J Urol 2000, 164:532-536. 10.1016/S0022-5347(05)67418-6, 10893639.
17. Karl A, Tritschler S, Hofmann S, Stief CG, Schindlbeck C. Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer. Eur J Med Res 2009, 14:487-490.
18. Naoe M, Ogawa Y, Morita J, Omori K, Takeshita K, Shichijyo T, Okumura T, Igarashi A, Yanaihara A, Iwamoto S, et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 2007, 109:1439-1445. 10.1002/cncr.22543, 17326057.
19. Kinjo M, Okegawa T, Horie S, Nutahara K, Higashihara E. Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients. Int J Urol 2004, 11:38-43. 10.1111/j.1442-2042.2004.00739.x, 14678183.
20. Lu JJ, Kakehi Y, Takahashi T, Wu XX, Yuasa T, Yoshiki T, Okada Y, Terachi T, Ogawa O. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. Clin Cancer Res 2000, 6:3166-3171.
21. Fujii Y, Kageyama Y, Kawakami S, Kihara K, Oshima H. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res 1999, 90:753-757.
22. Okegawa T, Hayashi K, Hara H, Nutahara K, Higashihara E. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer. Int J Urol 2010, 17:254-258. 10.1111/j.1442-2042.2010.02454.x, 20148989.
23. Ribal MJ, Mengual L, Marin M, Algaba F, Ars E, Fernandez PL, Oliva R, Villavicencio H, Alcaraz A. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging. Anticancer Res 2006, 26:411-419.
24. Retz M, Lehmann J, Roder C, Weichert-Jacobsen K, Loch T, Romahn E, Luhl C, Kalthoff H, Stockle M. Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients. Eur Urol 2001, 39:507-515. discussion 516-507, 10.1159/000052496, 11464030.
25. Soria JC, Morat L, Durdux C, Housset M, Cortez A, Blaise R, Sabatier L. The molecular detection of circulating tumor cells in bladder cancer using telomerase activity. J Urol 2002, 167:352-356. 10.1016/S0022-5347(05)65467-5, 11743355.
26. Guzzo TJ, McNeil BK, Bivalacqua TJ, Elliott DJ, Sokoll LJ, Schoenberg MP. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy. Urol Oncol 2009,
27. Rink M, Chun FK, Minner S, Friedrich M, Mauermann O, Heinzer H, Huland H, Fisch M, Pantel K, Riethdorf S. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer. BJU Int 2011, 107:1668-1675. 10.1111/j.1464-410X.2010.09562.x, 20735381.
28. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31. 10.1186/1471-2288-6-31, 1552081, 16836745.
29. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001, 323:157-162. 1120791, 11463691.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
31. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006, 6:50. 10.1186/1471-2288-6-50, 1626481, 17038197.
32. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001, 323:101-105. 10.1136/bmj.323.7304.101, 1120714, 11451790.
33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. 2127453, 9310563.
34. Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma W, Zhao W, Wang J, Yang M. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Res Treat 2011,
35. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003, 326:219. 10.1136/bmj.326.7382.219, 1125071, 12543843.
36. Nakanishi Y, Toyoizumi S, Nakajima A, Hamada C. Subgroup Analysis in Meta-Analysis: a comparison of different methods. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku 2007, 12:13-24.
37. Gazzaniga P, Nofroni I, Gandini O, Silvestri I, Frati L, Agliano AM, Gradilone A. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer. Oncol Rep 2005, 14:1199-1202.
38. Champelovier P, Mongelard F, Seigneurin D. CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 1999, 19:2073-2078.
39. Okegawa T, Kinjo M, Nutahara K, Higashihara E. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer. J Urol 2004, 171:1461-1466. 10.1097/01.ju.0000118648.29024.b7, 15017198.
40. Li SM, Zhang ZT, Chan S, McLenan O, Dixon C, Taneja S, Lepor H, Sun TT, Wu XR. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. J Urol 1999, 162:931-935. 10.1097/00005392-199909010-00093, 10458411.
41. Desgrandchamps F, Teren M, Dal Cortivo L, Marolleau JP, Bertheau P, Villette JM, Cortesse A, Teillac P, Le Duc A, Hamdy FC. The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer. Br J Cancer 1999, 81:832-834. 10.1038/sj.bjc.6690771, 2374308, 10555753.
42. Naoe M, Ogawa Y, Takeshita K, Iwamoto S, Miyazaki A. Use of the CellSearch Circulating Tumor Cell Test for monitoring urothelial cancer: two case reports of metastatic urothelial cancer. South Med J 2008, 101:439-441. 10.1097/SMJ.0b013e3181684fe1, 18360334.
43. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904. 10.1158/1078-0432.CCR-04-0378, 15501967.
44. Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF. Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol 2009, 20:305-308.
45. Osman I, Kang M, Lee A, Deng FM, Polsky D, Mikhail M, Chang C, David DA, Mitra N, Wu XR, et al. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients. Int J Cancer 2004, 111:934-939. 10.1002/ijc.20366, 15300806.
46. Yuasa T, Yoshiki T, Isono T, Tanaka T, Hayashida H, Okada Y. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol 1999, 6:286-292. 10.1046/j.1442-2042.1999.00064.x, 10404304.
47. Yuasa T, Yoshiki T, Tanaka T, Kim CJ, Isono T, Okada Y. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. Jpn J Cancer Res 1998, 89:879-882.
48. Gradilone A, Petracca A, Nicolazzo C, Gianni W, Cortesi E, Naso G, Vincenzi B, Cristini C, De Berardinis E, Di Silverio F, et al. Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU Int 2010, 106:710-715. 10.1111/j.1464-410X.2009.09130.x, 20128783.
49. Meye A, Bilkenroth U, Schmidt U, Fussel S, Robel K, Melchior AM, Blumke K, Pinkert D, Bartel F, Linne C, et al. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. Int J Oncol 2002, 21:521-530.
50. Gazzaniga P, Gandini O, Giuliani L, Magnanti M, Gradilone A, Silvestri I, Gianni W, Gallucci M, Frati L, Agliano AM. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin Cancer Res 2001, 7:577-583.
51. Gazzaniga P, Gradilone A, Frati L, Agliano AM. Epidermal growth factor receptor mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure. Clin Cancer Res 2001, 7:4288-4289.
52. Kaneda T, Hoshi S, Mao H, Takahashi T, Suzuki K, Sato M, Orikasa S. Detection of urogenital malignant cells in the peripheral blood by nested RT-PCR using keratin 19 mRNA. Nippon Hinyokika Gakkai Zasshi 1998, 89:33-42.
53. Angulo JC, Ferruelo A, Rodriguez-Barbero JM, Nunez C, de Fata FR, Gonzalez J. Detection and molecular staging of bladder cancer using real-time RT-PCR for gelatinases (MMP-2, MMP-9) and TIMP-2 in peripheral blood. Actas Urol Esp 2011, 35:127-136.
54. Loberg RD, Fridman Y, Pienta BA, Keller ET, McCauley LK, Taichman RS, Pienta KJ. Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia 2004, 6:302-309. 10.1593/neo.03484, 1502117, 15256052.
55. Koutsilieris M, Lembessis P, Luu-The V, Sourla A. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen. Clin Exp Metastasis 1999, 17:823-830. 10.1023/A:1006783330996, 11089880.
56. Sawabata N, Okumura M, Utsumi T, Inoue M, Shiono H, Minami M, Nishida T, Sawa Y. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg 2007, 55:189-192. 10.1007/s11748-007-0101-2, 17554991.
57. Lembessis P, Msaouel P, Halapas A, Sourla A, Panteleakou Z, Pissimissis N, Milathianakis C, Bogdanos J, Papaioannou A, Maragoudakis E, et al. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy. Clin Chem Lab Med 2007, 45:1488-1494. 10.1515/CCLM.2007.301, 17924845.
58. Nezos A, Lembessis P, Sourla A, Pissimissis N, Gogas H, Koutsilieris M. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance. Clin Chem Lab Med 2009, 47:1-11. 10.1515/CCLM.2009.009, 19055471.
59. Cheng L, Zhang S, MacLennan GT, Williamson SR, Lopez-Beltran A, Montironi R. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 2011, 42:455-481. 10.1016/j.humpath.2010.07.007, 21106220.